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Summary 
Class II major histocompatibility complex (MHC) genes encode for oe/13 chain pairs that are 
constitutively expressed principally on mature B cells and dendritic cells in mice. These gene 
products are easily induced on macrophages with cytokines, and may also aberrantly appear on 
the surface of epithelium during immune injury. The appearance of class II determinants in 
parenchymal tissue potentially renders these somatic cells  capable of antigen presentation to 
circulating  CD4 +  T  lymphocytes,  and  their  absence  may be  protective for  normal  tissues 
expressing self-antigens. The low surface class II expression observed on parenchymal cells generally 
correlates with low levels of mRNA,  suggesting that transcription rate is a major element in 
class II regulation. To understand the transcriptional mechanism maintaining low basal surface 
expression of class II in somatic cells, we transiently transfected mini-gene reporter constructs 
to study the regulation of the murine A/3 promoter in a cultured renal epithelial cell line. We 
describe here a negative c/s-acting regulatory region located between - 552 and -489 bp upstream 
of the A~/cap site that silences the transcriptional activity of the A/3 promoter in epithelial cells 
in an orientation-dependent manner, and is also able to silence a heterologous promoter. This 
region is not active in class II-expressing B cells (BAL-17) in culture, but is functional in two 
other murine class II-negative cell lines,  fibroblasts and thymoma T  cells.  Using competition 
electrophoretic mobility shift assays, we have localized the core protein binding site within this 
region to an 8-10-bp response element, designated A~3NILE, at  -543 to  -534 bp.  A nuclear 
extract from BAL-17 cells does not bind to this element. Mutation of this site abrogates the 
transcriptional silencing activity of the region. We conclude that the transcription of class II-A/3 
in parenchymal cells, and some lymphocytes, can be actively repressed by an upstream silencing 
element. 
T 
he gene products of the class II region of the MHC are 
required for the recognition  of antigen by CD4 + T 
lymphocytes (1). Class II molecules are normally expressed 
constitutively in mature B lymphocytes (2) and dendritic cells 
(3), and are easily induced in antigen-presenting macrophages 
with IFN-'r or TNF-ot (4). Other somatic cells, such as organ 
epithelium, normally express little or no class II on their cell 
surface, but can increase their expression during episodes of 
local inflammation. This upregulation has been noted in such 
settings as type I diabetes mellitus (5), GVHD (6), and var- 
ious forms of tubulointerstitial nephropathy (7, 8). Again, 
IFN-3, has been implicated as the primary mediator (for reviews 
see references 9  and 10). 
Under circumstances of increased class II expression, some 
nonlymphoid cells (11-13) including renal tubular cells (14--17), 
are capable of presenting both self and foreign antigen to 
CD4 + T  lymphocytes or hybridomas. The surface expres- 
sion of class II as a gene product correlates well with levels 
of mRNA transcript, and a variety of studies suggest that 
levels of mtLNA encoding AoeA~/EaE/3 are regulated by 
transcriptional controls rather than by modulation of stability 
of transcript levels (9).  Transcript levels are generally abun- 
dant in mature B cells, and very low in somatic parenchymal 
cells.  Thus,  an insight into how class II determinants are 
normally repressed in somatic cells, particularly at the tran- 
scriptional level,  may be important  in  understanding the 
antigen-presenting function of parenchymal cells in contrib- 
uting to the maintenance of a local immune response against 
self (8,  18,  19). 
The c/s-acting response elements and associated tram-acting 
233  J. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/94/07/0233/08  $2.00 
Volume 180  July 1994  233-240 nuclear proteins involved in the positive enhancement of class 
II transcription  in murine and human lymphoid cells have 
been  well  characterized,  with  most  of the  key  elements 
clustering in a proximal promoter region in the first 200 bp 
upstream of the transcription start site (9). Two lines of evi- 
dence suggest that the absence of class II expression on other 
cell types is at least partly a function of active silencing by 
negative-acting nuclear factors, as opposed to simply a lack 
of transcriptional enhancers. First, fusion of class II-positive 
B cells with either class II-negative plasma cells (20) or fibrosar- 
coma cells (21) extinguishes both basal and inducible mRNA 
expression of class II genes in the hybrid.  Second, many of 
the trans-acting proteins that bind  to the conserved X  and 
Y box promoter elements upstream of all class II genes can 
be detected in both class II-positive and -negative cell lines 
(22,  23),  although it has been suggested that  these do not 
occupy their binding  sites in class II-negative cells in vivo 
(22). Here we describe a novel c/s-acting element upstream 
of the murine A3 gene which acts to silence transcription 
of that gene in low class II-expressing renal tubular epithe- 
lium, fibroblasts, and T cells, but not in class II-positive B cells. 
Materials and Methods 
Cell  Lines.  MCT  epithelium  is  a  low  class II-expressing 
(AotAB s§  s-) murine proximal renal tubular cell line (14) 
that has been maintained in culture in DMEM supplemented with 
10% FCS, 100 U/ml penicillin, and 100/zg/ml streptomycin. BAL-17 
is an H-2  a ]3 lyrnphoma cell line that expresses high levels of class 
II (kindly provided by Dr. John Monroe, University of Pennsyl- 
vania; 24), and was maintained in RPMI 1640 medium with 10% 
FCS, penicillin, and streptomycin, and 5  x  10 -5 M 2-ME. NIH- 
3T3 is a class II-negative murine fibroblast cell line maintained 
in media described for MCT cells, and 2]34 is a class II-negative 
murine T cell thymoma line (kindly provided by Dr. Helen QuiU, 
University of Pennsylvania) maintained in media described for the 
BAh17 cell line, 
Plasraids.  The plasmids  8.54,  8.64,  12.19, and  B9  contain, 
respectively, - 322,  - 489,  - 669, and - 2,600 bp of genomic DNA 
upstream of the AB cap site  (taken  from a combination of H-2 
haplotypes b, d, and k) placed 5' of the chloramphenicol acetyltrans- 
ferase (CAT) gene (25). AoCAT contains the CAT gene with no 
promoter dements, and SV2CAT contains the CAT gene driven 
by an SV40 enhancer and promoter. SprCAT contains the SV40 
enhancerless promoter. The plasmids A669/566.8 and A669/489.8 
were constructed by cloning a 103-bp fragment (-669 to  -566) 
and a 179-bp fragment (-669 to  -489), respectively, from 12.19, 
into the unique SalI site at the 5' end of 8.54 in the forward (F) 
and reverse (R) orientations. The plasmid A552/489.8 was con- 
structed by PCR amplification (26, 27) of a 63-bp segment from 
position -552 to -489 of plasmid 12.19 using flanking oligomers 
5'-gtcgacCAATGCTTTCCATTATTA-Y and 5'-gtcgacCTCTAG- 
GTTTTGATAAGC-3' (lower case letters represent added SalI re- 
striction site). PCR amplification reactions were performed using 
the GeneAmp kit  TM (Perkin Elmer Cetus, Norwalk, CT) with 40 
pM of  primer, 200 #M of each dNTP, amplification buffer (10 mM 
Tris-HC1,  pH  8.3,  50 mM  KC1, 1.5 mM MgC12, and 0.001% 
gelatin) and 1.25 units Taq polymerase (27). 40 cycles of amplification 
were completed by annealing at 55~  for 90 s, performing the 
extension step for 120 s at 72~  and the denaturation step  for 
60 s at 92~  The amplification products were subcloned into the 
pCRII vector (Invitrogen, LaJolla, CA), and then transferred into 
the Sail site of 8.54, again in both orientations. This same frag- 
ment was also cloned into the SalI site upstream of the promoter 
of SprCAT to create A552/489.Spr. Plasmid  A552/489M.8 was 
constructed in a similar manner to A552/489.8 except that the 5' 
primer  was  replaced  with  the  mutated  primer  gtcgacAGCT- 
CAATGCTTTCCATTAGGCCCCA (mutation underlined). The 
insertional orientation and sequence of all constructed plasmids were 
verified by dideoxy chain termination (26,  27). 
Detection of  A~ mRNA by Northern Hytnidization.  Cultured cells 
were washed in RNase-free PBS, and poly(A) + mRNA was ex- 
tracted using the FastTrack  oligo(dT)-cellulose kit (Invitrogen). 
5  #g  poly(A) §  mRNA  was  electrophoresed through  a  1.2% 
agarose gel with 2.2 M formaldehyde.  The RNA was blotted by 
capillary action onto a GeneScreen membrane (New England Nu- 
clear, Boston, MA), prehybridized, and hybridized with a 0.79-kb 
fragment from cDNA  clone p71sa  encoding murine AB  (26). 
Selected filters were stripped and rehybridized with a cDNA probe 
encoding the housekeeping gene glyceraldehyde-3-phosphate  de- 
hydrogenase (GAPDH) to account for small loading and transfer 
variations. 
Transfections and CAT Assay.  Transient transfections of MCT, 
2B4, and 3T3 cells were carried out using calcium phosphate precipi- 
tation (28); replicate experiments were performed as indicated in 
the figure legends.  5  x  105 MCT cells were plated in 60-mm 
dishes and transfected 24 h later with 10 #g of plasmid DNA (or 
equimolar equivalents),  incubated in 5% CO2 at 37~  for 24 h, 
after which time the precipitate was removed and the cells were 
incubated for a further 24 h in complete medium. Cells were lysed 
by repeated freeze-thaw cycles. Transfections of BAL-17 cells were 
carried out using DEAE-dextran (29). 107 BAL-17 cells were trans- 
fected with 20 #g plasmid DNA in 500 #g/ml DEAE-dextran for 
30 rain followed by a 3-rain shock in 10% DMSO. Cells were har- 
vested  64 h after transfection. CAT assays were performed with 
all cell lysates heat inactivated at 65~  for 10 rain, and incubated 
for 2 h in the case of MCT cells, or 16 h in the case of BAL-17 
cells (28). Loading of cell lysates for incubation was normalized 
for protein content. 
Nuclear Extract Preparation and Gel Shift Assay.  MCT nuclear 
extracts were prepared according to the method of Dignam et al. 
(30) with the following modifications: three additional protease 
inhibitors, leupeptin,  aprotinin, and pepstatin A (Boehringer Mann- 
heim Biochemicals,  Indianapolis,  IN) were added to all buffers. 
Nuclei were extracted in 20 mM Hepes,  15% glycerol, 1.5 mM 
MgC12, 5 mM dithiothreitol (DTT), 0.4 M KC1, 1 mM EDTA, 
and 0.5% NP-40. Buffer D contained 15% glycerol and 0.5 mM 
ZnSO4,  but was  otherwise unchanged.  BAIA7 nuclei were ex- 
tracted in the presence of 0.43 M NaC1 rather than KC1, and in 
the absence of NP-40. The probe $89A was created by amplification 
of an 88-bp fragment from -605 to -517 ofplasmid 12.19 using 
the flanking oligomers 5'-gtatacGCAGGGCTGAGACACACATTA- 
3' and 5'-gtcgacAGAGCAGTGTGATGTGGTT-3'.  The product was 
cloned into the vector pCR II and digested with Accl to produce 
5' overhangs  which were filled in with [32p]dCTP and [3~p]dATP 
(Amersham Life Sciences, Arlington Heights, IL) using Klenow 
fragment polymerase.  80,000 cpm of probe was incubated with 
15/~g of nuclear extract in the presence of 2 #g poly d(IC), other 
competitor DNA as indicated, 5% glycerol, 50 mM NaC1, 10 mM 
Tris (pH 7.9), 1 mM EDTA, 5 mM MgC12, 1 mM DTT, and 3/zg 
BSA in a 15-/,1 volume for 15 rain at 21~  Reaction products were 
electrophoresed through a 5% polyacrylamide gel in 0.Sx  T]3E 
(Tris-borate/EDTA) at 10 V/cm for 2 h. The gels were dried and 
exposed to x-ray film without enhancement overnight. 
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MCT Epithelial Cells Express Low but Detectable Levels of 
Aft mRNA.  We sought to determine the transcriptional 
mechanism whereby parenchymal epithelium maintains im- 
munologic neutrality by means of low MHC class II ex- 
pression,  and made use of a renal tubular cell line to do so. 
MCT epithelial cells normally express little to no Ac~/A~  s 
on their cell surface, but this expression  can be upregulated 
somewhat with IFN-3,  (8).  Unlike mature B  cells which 
constitutively express class II determinants, MCT cells would 
be predicted to have very low levels of mlLNA encoding 
class II. Fig. 1 presents a 10-d exposure of a Northern blot 
of the A/~ mRNA message level in MCT ceils compared 
with the class II-expressing BAL-17 B cell line. Basal class 
II mRNA message levels in MCT cells are clearly much lower 
than in B cells. We have also previously isolated full-length 
cDNA clones encoding A~ from an MCT library, sequence 
analysis of which indicated that there are no mutations in 
the coding region of AB which would explain its low sur- 
face abundance by aborted translation (26). 
A  DNA Segment Upstream of the Aft Gene Silences the Ho- 
mologous and a Heterologous Promoter in MCT Cells.  In Fig. 
2, a representative transfection of MCT cells with A/~ gene 
deletion constructs demonstrates strong CAT activity with 
the shorter promoter segments which drops off in activity 
between  -669  and  -489 bp, indicating the possible  pres- 
ence of a negative cis-acting element in this region. The posi- 
tion independence of this region was established by creating 
plasmid A669/489.8,  in which region  -669 to  -489 was 
ligated directly to the homologous proximal promoter for 
A~ contained in a 322-bp  segment upstream of the gene. 
As can be observed in Fig. 3 A,  this region was still able 
to silence the strong positive CAT activity of the downstream 
region in MCT cells, but only when placed in the forward 
orientation (F); similar results were observed with 3T3 fibro- 
blasts (Fig. 3 B) and 2B4 thymoma T cells (Fig. 3 C). Trans- 
fection of BAL-17 cells with these constructs (Fig. 4), how- 
ever,  revealed  no  silencing  of proximal  CAT  activity by 
Figure  1.  Northern  blot for AB transcripts  in BAL-17  B cells  and MCT 
renal epithelium. 5/xg poly(A)  + RNA extracted  from  BALl7 cells (lane 
1) or MCT cells (lane  2) were  fractionated  in a 1.2% agarose  gel, blotted, 
and probed with a 790-bp AB cDNA probe and exposed for 10 d. The 
blot was stripped and reprobed  with a cDNA probe for the housekeeping 
gene GAPDH. 
A669/489.8, suggesting the absence of a relevant trans-acting 
factor in these class II-expressing B cells. 
To functionally  map the silencing region more closely, fur- 
ther constructs were created in which portions of this region 
were linked to the proximal homologous promoter (31), as 
diagrammed in Fig. 5. Transfection of these constructs into 
MCT cells further localized the silencing element to a region 
between -552 and -489. Again, the orientation dependence 
of this silencing effect is evident. This same region was also 
able to silence the heterologous SV40 enhancerless promoter, 
as shown in Fig. 6. This region in A/3  s was of identical se- 
quence to that found in the genomic DNA used to assemble 
the original A~  a,a,k CAT constructs used above (25),  with 
the exception of a single base pair substitution at position 
-547. 
Mapping  the  Core Binding Site  of the  Putative Silencing 
Factor.  Gel shift analysis was performed using an 88-bp probe 
from  -605  to  -517,  and revealed one major shifted band 
of interest (Fig. 7, lane 1). Competition analysis using 100- 
fold molar excess of the unlabeled double-stranded oligomers 
diagrammed in Fig. 7 revealed that the $12 oligonudeotide 
(lane 3), but not $11 or $14 (lanes 2 and 4), was able to corn- 
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Figure  2.  Transient  transfection 
of deletion constructs into MCT 
cells. (Right) Representative CAT 
experiment derived from transfec- 
tion of the diagrammed  constructs. 
All numbering of constructs rep- 
resents the number  of  base pairs  up- 
stream of  the transcription  start site 
for the A/3 gene (+1). Radioactive 
spots were  cut out of the TIC plate 
and counted,  and expressed as per- 
cent acetylation  relative  to SV2CAT, 
which was arbitrarily  set at 100%. 
Values represent the average  of  three 
independent transfections. %  acetylatioa 
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Figure  3.  Effect of  -669  to  -489  region on homologous promoter 
in MCT cells  (A), 3T3 fibroblasts (B), and 2B4 thymoma T  cells  (C). 
The  -669 to  -489 region was linked directly to the proximal promoter 
region  (contained  in a 322-bp  segment upstream  of the cap site)  in the 
forward (F)  and reverse (R)  orientation.  Percent acetylation  (average of 
three independent  transfections) is expressed relative to that of 8.54, which 
was set at  100%. 
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Figure  4,  Effect of  -669  to  -489  region  on homologous promoter 
in BAL-17 cells.  Results  expressed  as described  in legend to Fig. 3. 
pete with  the labeled probe,  narrowing the binding  site of 
the relevant  nuclear protein to the region between  -  556 and 
-  532 bp.  By competing with mutants of the $12 oligonu- 
cleotide (lanes 5-9 [32]), it was observed that only M.4 and 
M.5  (Fig.  7, lanes  7 and 8) fail to abolish the shifted band, 
indicating that the base pairs mutated in these two oligomers 
are essential for the binding of the putative silencer protein. 
The core binding site was thus localized to an 8-10-bp seg- 
ment, (CC)ATTATTAA, from  -  543 to  -  534 bp, which was 
designated A3NRE.  The other faint bands observed on gel 
shift were either not consistently present or were not abol- 
ished by competition with cold full-length probe (data not 
shown),  and were thus not felt to represent  specific  protein 
binding.  As demonstrated  in Fig.  8,  this binding  complex 
was  absent  in  an extract  derived  from  BAL-17  cells. 
To establish the functional importance of this binding site, 
a mutation ([CC]ATTAGGCC)  was introduced into a CAT 
construct  in  the  last  four  nudeotides  of A~NRE.  Thus, 
plasmid A552/489M.8  links the  -556 to  -489 region, con- 
taining a mutation of bp  -537 to  -534,  in a forward orien- 
tation to the homologous promoter region. As shown in Fig. 
9, mutation of the binding site largely abrogates the silencing 
activity  of this  region. 
Discussion 
The immunologic implications of aberrant  expression of 
class  II MHC  gene products on nonlymphoid cells,  as seen 
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Figure  5.  Localization  of  silencer  region  to 
-552 to  -489 bp. Diagrammed constructs were 
transfected into MCT cells with results expressed 
as described in legend to Fig. 3. 
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Figure 6,  Silencer  region  can repress  a heterologous  promoter.  The - 552 
to -489 silencer region was linked to the enhancerless SV40 promoter 
transfected  into MCT cells.  Percent  acetylation  is expressed  relative  to that 
for the SV40 promoter (Spr) alone. 
in a wide array of settings and likely mediated primarily by 
IFN-3', have been the subject of considerable interest in re- 
cent years. Although several groups have been able to dem- 
onstrate a T  cell proliferative response to intact (15, 33) or 
processed  (11) antigen presented by class II-expressing pa- 
renchymal cells, implying that such cells contribute, under 
certain pathologic conditions, to the local immune response, 
others have suggested that such "nontraditional" antigen pre- 
sentation may in fact lead to T  cell  anergy, and thus con- 
tribute  to  peripheral  self-tolerance  (34).  In  either  event, 
studying the normal mechanisms maintaining low epithelial 
class II expression  (and thus immunologic silence) will con- 
tribute to an understanding of issues pertaining to peripheral 
tolerance and organ-specific  autoimmunity. 
It has become increasingly appreciated  that transcription 
of eukaryotic genes may be modulated by negative-acting ele- 
ments in addition to the transcriptional enhancers that have 
long been recognized. Since the first description of silencing 
elements in yeast (35), numerous studies have demonstrated 
factors that exert a negative effect on the transcription of a 
wide range of genes (31, 32, 36,  37) including MHC class 
II (38).  That such a silencing factor might be operative in 
suppressing the transcription of class II genes in nonexpressing 
cells is suggested by fusion studies that have demonstrated 
extinction of class II expression  in hybrids of class II-nega- 
tive and -positive cells (20,  21). In one of these (21), mul- 
tiple clones of four independent fusions of  L929 fibrosarcoma 
cells with splenic B cells were studied for both basal and in- 
ducible class II message and gene product.  Although the 
hybrids retained expression of class I genes derived from both 
fusion partners and retained the E~ gene at the genomic level, 
none of the clones had any detectable class n expression. Similar 
findings were noted using transient fusion techniques, so that 
chromosomal loss appeared not to have been the mechanism 
of class II extinction. A more recent study found reactiva- 
tion of low levels of class II transcript in plasmacytoma cells 
and human T cells on transient fusion with B lymphoblastoid 
cells  and  to  a  much lesser  extent  with  splenocytes (39). 
Whereas these opposing results are difficult to reconcile,  the 
study by Stuart et al. (21) is highly suggestive of the presence 
of a negative trans-acting  factor operating in at least  some 
cell types. In addition, two studies have previously demon- 
strated functional evidence of a class II silencer  element in 
the region we report. Boss and Strominger (40), using stable 
transfection of DOff constructs into fibroblasts, found a three- 
fold increase in transcription on deletion of upstream DNA 
from  -2,500  to  -590 bp,  and a further 3.3-fold increase 
on deletion to  -159 bp. Thanos et al. (41), using transient 
transfection of Eot constructs into a xeroderma cell line, found 
an increase in basal expression on deletion from - 873 to - 353 
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Figure  7.  Gel shift analysis  of silencer 
region. Labeled probe $89A (sequence 
shown) was incubated  with MCT nuclear 
extract without (lane 1), or with 100-fold 
molar excess of  an  unlabeled double- 
stranded  oligonudeotide  as indicated  (lanes 
2-9).  (-) Nucleotide identity with the 
$89A probe. (Arrow) Position of major 
shifted  band. Base  pairs found  to be essen- 
tial  for protein  binding  by competition  anal- 
ysis are underlined. 
237  Albert  et al. Figure 8.  Gel shift of  BAL-17  nuclear ex- 
tract. $89A  probe  was incubated  with MCT 
(lane I) or BAL-17  (lane 2) nuclear extract. 
(Arrow) Position of major shifted band. 
bp. To date, the region in the range of -1,200 to  -400 bp 
upstream of the transcription  start site for class II genes has 
not been examined  in  further  detail. 
We have mapped  a novel silencing  region  to  a segment 
between  -552  and  -489 bp upstream  of the routine  A3 
cap site.  This region, which acts in a position-independent, 
but orientation-dependent  manner,  is  active in  a low class 
II-expressing  renal  tubular epithelial  cell line  (MCT),  but 
not  in  a class  II-positive B  lymphoma  cell line  (BAL-17). 
Gel shift competition analysis  using a series of mutated oli- 
gonucleotides localized the core protein binding site, termed 
A3NRE,  to an 8-10-bp AT-rich element at position  -543. 
Mutation of this binding site abolished the ability of the re- 
gion to silence the transcriptional activity of the downstream 
positive-acting elements of the A3 gene when linked directly 
upstream  of them.  Our studies of this region in two other 
murine class II-negative cell lines  (one a fibroblast and the 
other a T cell) suggest that this upstream silencer may repre- 
sent a relatively ubiquitous mechanism of class II transcrip- 
tional  repression. 
A search of the GenBank  TM database revealed no homology 
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Figure 9.  Effect  of  mutation ofA/~NRE.  A552/489M.8  links silencing 
region -552 to -489 to proximal promoter region with a mutation in- 
troduced in bp  -537 to  -534 corresponding to the last four base pairs 
of A3NRE. (*) Site of mutation. Results are expressed as described  in 
legend to Fig. 3. 
between A3NtLE and other known transcriptional elements. 
However, a novel member of the bZIP family of DNA-binding 
proteins,  E4BP4,  has  recently been isolated from a human 
placental cDNA library (42), and its optimum binding site, 
(G/A)TTATGTAA(C/T), bears a marked degree of homology 
of A3NRE,  (CC)ATTATTAA(C).  Cotransfection  of  an 
E4BP4 expression plasmid with a reporter beating its binding 
site upstream of a heterologous promoter revealed it to have 
transcriptional  repressing activity. The function and distri- 
bution of this binding protein is currently unknown. Although 
A3NRE is not found in the first 1,296 bp 5' of the transla- 
tion start site in the Aot gene, the first 8 bp of the element, 
CCATTATT,  are found 480 bp upstream  of the  transcrip- 
tional  start  site of A3's  analogous  human  gene,  DQ3.  In 
fact, an examination of the proximal promoter region reveals 
a greater degree of identity of conserved elements between 
A3 and DQ3 than between A3 and Aot, with at least one 
element (a nuclear factor KB binding  site)  which is present 
in both Aot and DQot but not in the corresponding 3  chain 
promoters  (10).  Whether  Aot is coordinately silenced by a 
poorly conserved version of AfNRE or by an entirely different 
mechanism  remains  to be determined. 
Transcriptional  repression of eukaryotic promoters is medi- 
ated by DNA-binding proteins which act either by competing 
for DNA-binding sites, by quenching or sequestering of ac- 
tivator proteins, or by direct repression of the basal transcrip- 
tion complex (43, 44). The mechanism of action of the putative 
silencing protein that binds to ABNRE can only be specu- 
lated upon, but any model must take into account two key 
findings.  First,  Liou  et  al.  (45)  have  found  that  class  II- 
expressing cells possess three DNase I-hypersensitive sites in 
their Aot genes, at  -1,400 bp, in the first intron,  and in the 
proximal promoter region. The latter of these,  D2, was ab- 
sent in class  II-negative cell lines,  and on fusion of T  and 
B cells (in which class II expression was extinguished),  the 
authors demonstrated the absence of the D2 site derived from 
the Ace gene of either fusion partner in the hybrid. Second, 
it  has  been shown that  the class  II promoter  elements  are 
not occupied in vivo in class II-negative cell lines,  although 
their binding factors can be detected in in vitro gel shift assays 
(22). Thus, the A3NRE binding protein might be expected 
to act in a manner analogous to the or2 repressor of the yeast 
S.  cerevisiae,  which is able to place a nucleosome near a pro- 
moter site (46). This would have the effect of rendering the 
promoter both inaccessible to activating factors and insensi- 
tive to DNase  I.  However,  silencers  that  function  in  this 
manner  tend to demonstrate both position and orientation 
independence (43), and so the marked orientation dependence 
of ABNRE is somewhat puzzling.  A lesser degree of orien- 
tation dependence was noted when a 274-bp segment from 
the  first  intron  of the c~l(I)  collagen gene was placed up- 
stream of the promoter of that gene (36),  so our finding is 
not without precedent.  IFN-'y (or factors induced by it), which 
exerts its class II upregulating  effect through  the proximal 
promoter region (47), could disrupt this nucleosome struc- 
ture, as has been shown in the case of the glucocorticoid-glu- 
cocorticoid receptor complex and the murine mammary tumor 
238  A Cis-acting  Silencer Element Upstream of Class II-A3 in Epithelium virus promoter  (48).  Alternatively,  both constitutive class 
II-expressing and IFN-'y induced cells might produce a factor 
that is able to sequester the silencing protein and prevent its 
effects on promoter accessibility. A  fuller understanding of 
the mechanism  of action of the nuclear factor recognizing 
A/3NRE  must  await  isolation of this  protein. 
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